In:
The Open Medicinal Chemistry Journal, Bentham Science Publishers Ltd., Vol. 11, No. 1 ( 2017-11-30), p. 138-145
Abstract:
Selegiline is used to treat Parkinsonian patients. Other indications of its use have recently been discovered. Objective: Scouting special and beneficial side effects of selegiline treatment. Method: Two-year old male Wistar rats were daily treated with 0.25 mg/kg of selegiline s.c. (subcutaneous injection). The rats were sacrificed following a four-weeks’ treatment. Results: Mass of testes, number of sperms, progressive motility of sperms, and their viability definitely increased. Conclusion: Selegiline can successfully be used to stop/counterbalance certain symptoms of aging.
Type of Medium:
Online Resource
ISSN:
1874-1045
DOI:
10.2174/1874104501711010138
Language:
English
Publisher:
Bentham Science Publishers Ltd.
Publication Date:
2017
detail.hit.zdb_id:
2395968-X
SSG:
15,3
Permalink